dermatopathology david r. barron, md

1
Richfield Laboratory of Dermatopathology DERMATOPATHOLOGY David R. Barron, MD Medical Director, Dermatopathologist Phone: 1.800.541.8531 l Email: [email protected] Dermpath Diagnostics Richfield Laboratory of Dermatopathology 9844 Redhill Drive, Cincinnati, OH 45242 David R. Barron, MD is a board-certified dermatologist/dermatopathologist, who has been practicing dermatopathology for over 30 years. Dr. Barron is the Managing Director of the Dermpath Diagnostics Richfield Laboratory of Dermatopathology in Cincinnati, OH. He is nationally recognized as one of the top dermatopathologist in the country. Dr. Barron is actively involved in resident training. He hosts the largest, national dermatopathology review course for third year residents. He also hosts an annual session for Chicago area residents to help in their dermatopathology training, as well as other regional review courses in the Midwest. Board Certifications Dermatology Dermatopathology Fellowship Dermatopathology University of Cincinnati College of Medicine Cincinnati, OH Select Publications Langenberg A, Berger TG. Cardelli M, Rodman OG, Estes S, Barron D: Genital benign chronic pemphigus (Hailey-Hailey disease) presenting as condylomas. J Am Acad Dermatol 26: 951-955, 1992. Breneman D, Amornsiripanitch, Barron D, Bushong R, Peglow S: Granulomatous secondary syphilis in a patient with immunodeficiency virus infection. Cutis 44: 377-381, 1989. Bailey D, Barron D, Lucky A: Neutrophlic eccrine hidradenitis. Ped Dermatol 6:33-38, 1989. Lindholm JS, Barron DR, Williams M, Swerdlow S: Ki-1 positive cutaneous large cell lymphoma of T cell type: A report of an indolent subtype. J Am Acad Dermatol 20:342-348, 1989. McCullough A, Barron D, Mullen K, Petrilli M, Park MC, Mukhtar H, Bickers D: Fecal protoporphyrin excretion in erythropoietic protoporphyria: Effect of cholestyramine and bile acid feeding. Gastroenterology 94: 177-181, 1988. Barron D, Hirsch A, Buchbinder L, Pomeranz J: Folliculitis ulerythematosa reticulata. A report of four cases with a brief review of the literature. Pediatr Dermatol 4: 85-89, 1987. Barron DR, Davis BR, Pomeranz JR, Hines JD, Park CH: Cytophagic histiocytic panniculitis: a variant of malignant histocytosis. Cancer 55:2538-2541, 1985. DermpathDiagnostics.com Dermpath Diagnostics, any associated logos, and all associated Dermpath Diagnostics registered or unregistered trademarks are the property of DermpathDiagnostics. All third party marks – ® and ™ – are the property of their respective owners. ©2017 Dermpath Diagnostics Incorporated. All rights reserved. DBARRON 05/2017 Residency Dermatology Cleveland Metropolitan General Hospital Cleveland, OH Medical School George Washington University Medical School Washington, D.C.

Upload: others

Post on 19-Nov-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Richfield Laboratory of Dermatopathology

DERMATOPATHOLOGY David R. Barron, MD Medical Director, Dermatopathologist

Phone: 1.800.541.8531 l Email: [email protected]

Dermpath Diagnostics Richfield Laboratory of Dermatopathology

9844 Redhill Drive, Cincinnati, OH 45242

David R. Barron, MD is a board-certified dermatologist/dermatopathologist, who has been practicing dermatopathology for over 30 years. Dr. Barron is the Managing Director of the Dermpath Diagnostics Richfield Laboratory of Dermatopathology in Cincinnati, OH. He is nationally recognized as one of the top dermatopathologist in the country. Dr. Barron is actively involved in resident training. He hosts the largest, national dermatopathology review course for third year residents. He also hosts an annual session for Chicago area residents to help in their dermatopathology training, as well as other regional review courses in the Midwest.

Board Certifications Dermatology Dermatopathology

Fellowship Dermatopathology University of Cincinnati College of Medicine Cincinnati, OH

Select PublicationsLangenberg A, Berger TG. Cardelli M, Rodman OG, Estes S, Barron D: Genital benign chronic pemphigus (Hailey-Hailey disease) presenting as condylomas. J Am Acad Dermatol 26: 951-955, 1992.

Breneman D, Amornsiripanitch, Barron D, Bushong R, Peglow S: Granulomatous secondary syphilis in a patient with immunodeficiency virus infection. Cutis 44: 377-381, 1989.

Bailey D, Barron D, Lucky A: Neutrophlic eccrine hidradenitis. Ped Dermatol 6:33-38, 1989.

Lindholm JS, Barron DR, Williams M, Swerdlow S: Ki-1 positive cutaneous large cell lymphoma of T cell type: A report of an indolent subtype. J Am Acad Dermatol

20:342-348, 1989.

McCullough A, Barron D, Mullen K, Petrilli M, Park MC, Mukhtar H, Bickers D: Fecal protoporphyrin excretion in erythropoietic protoporphyria: Effect of

cholestyramine and bile acid feeding. Gastroenterology 94: 177-181, 1988.

Barron D, Hirsch A, Buchbinder L, Pomeranz J: Folliculitis ulerythematosa reticulata. A report of four cases with a brief review of the literature. Pediatr Dermatol 4:

85-89, 1987.

Barron DR, Davis BR, Pomeranz JR, Hines JD, Park CH: Cytophagic histiocytic panniculitis: a variant of malignant histocytosis. Cancer 55:2538-2541, 1985.

DermpathDiagnostics.comDermpath Diagnostics, any associated logos, and all associated Dermpath Diagnostics registered or unregistered trademarks are the property of DermpathDiagnostics. All third party marks – ® and ™ – are the property of their respective owners. ©2017 Dermpath Diagnostics Incorporated. All rights reserved. DBARRON 05/2017

ResidencyDermatologyCleveland Metropolitan General Hospital Cleveland, OH

Medical School George Washington University Medical School Washington, D.C.